Milestone Pharmaceuticals Inc. (MIST) Financials
MIST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 181.6 million | 163.4 million |
| March 31, 2026 | 193.7 million | 157.7 million |
| Dec. 31, 2025 | 113.6 million | 71.8 million |
| Sept. 30, 2025 | 87.8 million | 67.2 million |
MIST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | 3.1 million |
| March 31, 2026 | -16.1 million | 1.3 million |
| Dec. 31, 2025 | -12.8 million | 3.6 million |
| Sept. 30, 2025 | -9.8 million | 1.3 million |
MIST Net Income
No data available :(
MIST Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 170.6 million | 59.2 million | 862000 |
| March 31, 2026 | 184.2 million | 136.3 million | 366000 |
| Dec. 31, 2025 | 106.0 million | 57.2 million | 539000 |
| Sept. 30, 2025 | 82.6 million | 56.2 million | 519000 |
MIST Shares Outstanding
MIST Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.5 million | 22.6 million | - |
| March 31, 2026 | 44999 | 3.4 million | 4.8 million | - |
| Dec. 31, 2025 | 11000 | 5.5 million | 13.3 million | 8.2 million |
| Sept. 30, 2025 | 1982 | 4.0 million | 7.9 million | 4.6 million |
MIST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 559000 | 32000 |
| March 31, 2026 | 238000 | 70000 |
| Dec. 31, 2025 | 1.5 million | 34000 |
| Sept. 30, 2025 | - | 24999 |
MIST
Price: $1.10
52 week price:
Earnings Per Share: -0.65 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 563278
Market Capitalization: 136.9 million